HUP0101707A2 - Új antiasztmás, antiallergiás, gyulladásgátló, immunmoduláló és neuroprotektív hatású 1,2,5-szubsztituált 1,2-dihidroindazol-3-on-származékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Új antiasztmás, antiallergiás, gyulladásgátló, immunmoduláló és neuroprotektív hatású 1,2,5-szubsztituált 1,2-dihidroindazol-3-on-származékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0101707A2 HUP0101707A2 HU0101707A HUP0101707A HUP0101707A2 HU P0101707 A2 HUP0101707 A2 HU P0101707A2 HU 0101707 A HU0101707 A HU 0101707A HU P0101707 A HUP0101707 A HU P0101707A HU P0101707 A2 HUP0101707 A2 HU P0101707A2
- Authority
- HU
- Hungary
- Prior art keywords
- choh
- mono
- asthmatic
- indazol
- allergic
- Prior art date
Links
- -1 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones Chemical class 0.000 title abstract 13
- 230000003266 anti-allergic effect Effects 0.000 title abstract 2
- 230000001088 anti-asthma Effects 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 239000000924 antiasthmatic agent Substances 0.000 title abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 230000000324 neuroprotective effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- SWEICGMKXPNXNU-UHFFFAOYSA-N 1,2-dihydroindazol-3-one Chemical class C1=CC=C2C(O)=NNC2=C1 SWEICGMKXPNXNU-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000005427 anthranyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány új (I) általános képletű 1,2,5-szubsztituált 1,2-dihidro-indazol-3-on-származékokra - ahol a képletben X jelentése -SO2-, -SO-,-(CH2)p-, -(CH2)p-O-, -(CH2)p-(C=O)-, -(CH2)p-(C=O)-NH-, -(CH2)p-CHOH-, -CHOH-(CH2)p-, -(CH2)p-CH=CH-, -CH=CH-(CH2)p- lehet, ahol pértéke 1, 2, 3 vagy 4, Y jelentése -(C=O)-, -(C=O)-NH-, -(C=O)-NH-(CH2)p-, -(C=O)-(CH2)p-, -(CH2)p-O-, -(CH2)p-(C=O)-, -(CH2)p--(C=O)-NH-, -(CH2)p-(C=O)-NH-(CH2)p-, -(CH2)p-CHOH-, -CHOH-(CH2)p-, -(CH2)p-CH=CH-, -CH=CH-(CH2)p- lehet, ahol p értéke 1, 2, 3 vagy 4, Zjelentése -O-, -O-(CH2)p- (p=1, 2, 3 vagy 4) vagy -NH-, -NH-(C=O)-, -NH-(C=O)-NH-, -NH-(C=O)-O-, -NH-CH2-(C=O)- vagy -NH-(C=O)-CH2, R1, R2és R3 jelentése azonos vagy eltérő és az alábbi lehet: 5-14gyűrűtagból álló mono-, bi- vagy triciklusos, telített vagyegyszeresen vagy többszörösen telítetlen karbociklus, előnyösenfenil-, naftil-, antranil-, fluorenilcsoport, 5-15 gyűrűtagból állómono-, bi- vagy triciklusos, telített vagy egyszeresen vagytöbbszörösen telítetlen, 1-6 heteroatomot, előnyösen N-, O- és/vagy S-atomot tartalmazó heterociklusos csoport, előnyösen tienil-,piridinil-, izoxazolil-, benziomidazolil-, benz[1,3]dioxolil-,pirimidinil-, kinolil-, kinazolinil-, morfolinil-, pirrolidinil-,pirrolil-, fenil[1,2,4]oxadiazolil- vagy feniltiazolilcsoport, és akarbociklusos, illetve heterociklusos csoportok lehetnek egyszeresenvagy többszörösen szubsztituáltak - előállításukra és gyógyászatihatóanyagkénti alkalmazásukra vonatkozik. A vegyületeknek antiasztmás,antiallergiás, gyulladásgátló és immunmoduláló tulajdonságai vannak. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821003A DE19821003A1 (de) | 1998-05-11 | 1998-05-11 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1999/002291 WO1999058504A1 (de) | 1998-05-11 | 1999-04-01 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver wirkung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101707A2 true HUP0101707A2 (hu) | 2002-03-28 |
| HUP0101707A3 HUP0101707A3 (en) | 2002-06-28 |
Family
ID=7867363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101707A HUP0101707A3 (en) | 1998-05-11 | 1999-04-01 | Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production them and pharmaceutical compositions containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6180637B1 (hu) |
| EP (1) | EP1077948A1 (hu) |
| JP (1) | JP2002514627A (hu) |
| KR (1) | KR20010025011A (hu) |
| CN (1) | CN1309642A (hu) |
| AR (1) | AR018605A1 (hu) |
| AU (1) | AU745796B2 (hu) |
| BG (1) | BG104910A (hu) |
| BR (1) | BR9911772A (hu) |
| CA (1) | CA2271837A1 (hu) |
| CO (1) | CO5021131A1 (hu) |
| DE (1) | DE19821003A1 (hu) |
| HK (1) | HK1038751A1 (hu) |
| HU (1) | HUP0101707A3 (hu) |
| IL (1) | IL139358A0 (hu) |
| NO (1) | NO20005698L (hu) |
| NZ (1) | NZ508646A (hu) |
| PL (1) | PL344254A1 (hu) |
| SK (1) | SK17082000A3 (hu) |
| TR (1) | TR200003302T2 (hu) |
| TW (1) | TW448163B (hu) |
| WO (1) | WO1999058504A1 (hu) |
| ZA (1) | ZA200006151B (hu) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| WO2008141385A1 (en) * | 2007-05-21 | 2008-11-27 | Biota Scientific Management Pty Ltd | Viral polymerase inhibitors |
| SG193454A1 (en) | 2011-03-14 | 2013-10-30 | Boehringer Ingelheim Int | Benzodioxane inhibitors of leukotriene production |
| WO2013012844A1 (en) | 2011-07-19 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| TW201350475A (zh) | 2012-03-06 | 2013-12-16 | Boehringer Ingelheim Int | 用於組合療法之白三烯素生成之苯并二噁烷抑制劑 |
| US8946203B2 (en) | 2012-03-06 | 2015-02-03 | Boehringer Ingelheim International Gmbh | Benzodioxane inhibitors of leukotriene production |
| JP6256467B2 (ja) | 2012-07-17 | 2018-01-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン生成を阻害するピラゾール誘導体 |
| JP2016523982A (ja) | 2013-07-15 | 2016-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン生成の阻害剤 |
| EP3022193B1 (en) | 2013-07-15 | 2017-04-26 | Boehringer Ingelheim International GmbH | Inhibitors of leukotriene production |
| KR20190017873A (ko) * | 2016-06-08 | 2019-02-20 | 썬리겐 헬쓰케어 아게 | 홀수의 탄소 원자를 갖는 지질 및 제약 조성물 또는 영양 보충제로서의 그의 용도 |
| CN113105409B (zh) * | 2021-04-06 | 2023-06-02 | 四川大学 | 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途 |
| CA3221177A1 (en) | 2021-11-01 | 2023-05-04 | Meghan Kerrisk Campbell | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3132916A1 (de) * | 1981-08-20 | 1983-03-03 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5179112A (en) * | 1985-04-17 | 1993-01-12 | Ici Americas Inc. | Heterocyclic amide derivatives and pharmaceutical use |
| IL84944A (en) * | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
| US5036083A (en) * | 1988-07-15 | 1991-07-30 | Ici Pharma | Heterocyclic agents |
| US5229408A (en) * | 1988-07-15 | 1993-07-20 | Ici Pharma | 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives |
| DE19610882A1 (de) * | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1998
- 1998-05-11 DE DE19821003A patent/DE19821003A1/de not_active Withdrawn
-
1999
- 1999-04-01 TR TR2000/03302T patent/TR200003302T2/xx unknown
- 1999-04-01 BR BR9911772-0A patent/BR9911772A/pt not_active IP Right Cessation
- 1999-04-01 SK SK1708-2000A patent/SK17082000A3/sk unknown
- 1999-04-01 HU HU0101707A patent/HUP0101707A3/hu unknown
- 1999-04-01 EP EP99950343A patent/EP1077948A1/de not_active Withdrawn
- 1999-04-01 AU AU42576/99A patent/AU745796B2/en not_active Ceased
- 1999-04-01 IL IL13935899A patent/IL139358A0/xx unknown
- 1999-04-01 PL PL99344254A patent/PL344254A1/xx unknown
- 1999-04-01 WO PCT/EP1999/002291 patent/WO1999058504A1/de not_active Application Discontinuation
- 1999-04-01 KR KR1020007012614A patent/KR20010025011A/ko not_active Application Discontinuation
- 1999-04-01 NZ NZ508646A patent/NZ508646A/xx unknown
- 1999-04-01 CN CN99808515A patent/CN1309642A/zh active Pending
- 1999-04-01 JP JP2000548308A patent/JP2002514627A/ja active Pending
- 1999-04-23 TW TW088106565A patent/TW448163B/zh not_active IP Right Cessation
- 1999-05-05 US US09/305,602 patent/US6180637B1/en not_active Expired - Fee Related
- 1999-05-07 CO CO99028290A patent/CO5021131A1/es unknown
- 1999-05-11 AR ARP990102212A patent/AR018605A1/es not_active Application Discontinuation
- 1999-05-11 CA CA002271837A patent/CA2271837A1/en not_active Abandoned
-
2000
- 2000-10-31 ZA ZA200006151A patent/ZA200006151B/en unknown
- 2000-11-03 BG BG104910A patent/BG104910A/xx unknown
- 2000-11-10 NO NO20005698A patent/NO20005698L/no not_active Application Discontinuation
-
2002
- 2002-01-17 HK HK02100376.2A patent/HK1038751A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005698D0 (no) | 2000-11-10 |
| CO5021131A1 (es) | 2001-03-27 |
| ZA200006151B (en) | 2000-12-06 |
| NZ508646A (en) | 2002-11-26 |
| HUP0101707A3 (en) | 2002-06-28 |
| DE19821003A1 (de) | 1999-11-18 |
| CA2271837A1 (en) | 1999-11-11 |
| JP2002514627A (ja) | 2002-05-21 |
| WO1999058504A9 (de) | 2000-02-03 |
| SK17082000A3 (sk) | 2001-09-11 |
| AU745796B2 (en) | 2002-03-28 |
| TW448163B (en) | 2001-08-01 |
| CN1309642A (zh) | 2001-08-22 |
| AU4257699A (en) | 1999-11-29 |
| BG104910A (en) | 2001-06-29 |
| WO1999058504A1 (de) | 1999-11-18 |
| PL344254A1 (en) | 2001-10-22 |
| IL139358A0 (en) | 2001-11-25 |
| BR9911772A (pt) | 2001-02-06 |
| NO20005698L (no) | 2001-01-08 |
| AR018605A1 (es) | 2001-11-28 |
| EP1077948A1 (de) | 2001-02-28 |
| HK1038751A1 (zh) | 2002-03-28 |
| TR200003302T2 (tr) | 2001-02-21 |
| KR20010025011A (ko) | 2001-03-26 |
| US6180637B1 (en) | 2001-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101707A2 (hu) | Új antiasztmás, antiallergiás, gyulladásgátló, immunmoduláló és neuroprotektív hatású 1,2,5-szubsztituált 1,2-dihidroindazol-3-on-származékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0101821A2 (hu) | Új antiasztmás, antiallergiás, gyulladásgátló, immunmoduláló és neuroprotektív hatású 1,5- és 3-O-szubsztituált 1H-indazol-származékok, eljárás az előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0002050A2 (hu) | Szubsztituált imidazolvegyületek, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| DE69301017D1 (de) | Von perhalogenierten sultonen abgeleiteten monomere,sowie aus diesen monomeren hergestellte polymere | |
| GEP20084367B (en) | Diazepinoindole derivatives as kinase inhibitors | |
| PT97888A (pt) | Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem | |
| ATE237327T1 (de) | Bizyclische pyrrolverbindungen, deren pharmazeutische zusammensetzungen und ihre verwendung als entzündungshemmende und immunmodulierende mittel | |
| CO5580735A2 (es) | Composicion para el tratamiento del cabello que comprende particulas compuestas de arcilla y una molecula organica cargada | |
| WO2000046198A8 (en) | Anti-inflammatory indole derivatives | |
| HUP9700358A2 (hu) | Új oxazolidinonszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| NZ524857A (en) | Piperidine compounds as anti-allergics | |
| DE60009561D1 (de) | Pigmentiertes glasartiges material dessen vorläufer damit beschichtete glaskörper und verfahren zu dessen herstellung | |
| HUP0402244A2 (hu) | Heterociklusos glicinamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| TW200633063A (en) | Producing method of film and semiconductor device using the film produced thereby | |
| AU2413995A (en) | Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase | |
| WO2002002562A3 (en) | Heteropolycyclic inhibitors | |
| US9409822B2 (en) | Friable-resistant dielectric porcelain | |
| AU683602B2 (en) | Process for encapsulating a waste material | |
| HUP9802407A1 (hu) | Eljárás kamptotecinszármazékok előállítására, valamint a közbenső termékként szolgáló vegyületek | |
| CO4340625A1 (es) | Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos | |
| HUP0303361A2 (hu) | Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| BR9510429A (pt) | Composto composição farmacêutica processo para produzir o composto e uso do composto | |
| ATE501158T1 (de) | Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| TW200500655A (en) | Color filter composition, method and apparatus for manufacturing a color filter having the same | |
| RS50571B (sr) | Postupak za proizvodnju derivata (3-okso-2,3-dihidro-1h-izoindol-1-1l)-acetil-gvanidina |